[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE391509T1 - Von lactobacillus casei ke01 stamm abgeleitete probiotische verbindungen - Google Patents

Von lactobacillus casei ke01 stamm abgeleitete probiotische verbindungen

Info

Publication number
ATE391509T1
ATE391509T1 AT01994262T AT01994262T ATE391509T1 AT E391509 T1 ATE391509 T1 AT E391509T1 AT 01994262 T AT01994262 T AT 01994262T AT 01994262 T AT01994262 T AT 01994262T AT E391509 T1 ATE391509 T1 AT E391509T1
Authority
AT
Austria
Prior art keywords
lactobacillus casei
strain
compounds derived
probiotic compositions
probiotic
Prior art date
Application number
AT01994262T
Other languages
English (en)
Inventor
A Naidu
Original Assignee
Probio Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probio Health filed Critical Probio Health
Application granted granted Critical
Publication of ATE391509T1 publication Critical patent/ATE391509T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/125—Casei
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y10S435/856—Lactobacillus casei

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Birds (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Physiology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT01994262T 2000-12-18 2001-12-17 Von lactobacillus casei ke01 stamm abgeleitete probiotische verbindungen ATE391509T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US25652800P 2000-12-18 2000-12-18

Publications (1)

Publication Number Publication Date
ATE391509T1 true ATE391509T1 (de) 2008-04-15

Family

ID=22972567

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01994262T ATE391509T1 (de) 2000-12-18 2001-12-17 Von lactobacillus casei ke01 stamm abgeleitete probiotische verbindungen

Country Status (13)

Country Link
US (1) US6797266B2 (de)
EP (1) EP1345613B1 (de)
JP (2) JP5186077B2 (de)
KR (1) KR20040018319A (de)
AT (1) ATE391509T1 (de)
AU (1) AU2002246679B2 (de)
BR (1) BR0116349A (de)
CA (1) CA2442602A1 (de)
DE (1) DE60133581T2 (de)
IL (1) IL156490A0 (de)
MX (1) MXPA03005465A (de)
NZ (1) NZ526443A (de)
WO (1) WO2002058712A2 (de)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7029702B2 (en) * 1998-07-07 2006-04-18 Ritter Natural Sciences Llc Method for increasing lactose tolerance in mammals exhibiting lactose intolerance
US20040197352A1 (en) * 1999-04-30 2004-10-07 Natarajan Ranganathan Methods of improving or augmenting kidney function
US7998470B2 (en) 1999-04-30 2011-08-16 Kibow Biotech, Inc. Compositions and methods improving renal function
US7026160B2 (en) * 1999-04-30 2006-04-11 Kibow Biotech, Inc. Oral bacteriotherapy compositions and methods
US20040161422A1 (en) * 1999-04-30 2004-08-19 Natarajan Ranganathan Nutritional compositions comprising probiotics
SE0003100D0 (sv) * 2000-09-01 2000-09-01 Probi Ab New strains
WO2002058712A2 (en) * 2000-12-18 2002-08-01 Probio Health Probiotic compounds derived from lactobacillus casei strain ke01
US7214370B2 (en) 2000-12-18 2007-05-08 Probiohealth, Llc Prebiotic and preservative uses of oil-emulsified probiotic encapsulations
PE20030283A1 (es) * 2001-07-26 2003-05-01 Alimentary Health Ltd Cepas de lactobacillus casei
US20030175305A1 (en) * 2002-01-08 2003-09-18 Garner Bryan E. Compositions and methods for inhibiting pathogenic growth
US20040028665A1 (en) 2002-01-08 2004-02-12 Garner Bryan E. Compositions and methods for inhibiting pathogenic growth
US7182943B2 (en) * 2002-05-15 2007-02-27 UNIVERSITé LAVAL Method and system for modulation of microbial cell characteristics
GB0212975D0 (en) * 2002-06-06 2002-07-17 Mars Uk Ltd Mammalian animal composition
WO2004000335A1 (en) * 2002-06-19 2003-12-31 The Board Of Regents Of The University Of Nebraska Lactic acid bacteria cultures that inhibit food-borne pathogens
WO2004028460A2 (en) * 2002-09-26 2004-04-08 Probiohealth, Llc Prebiotic and preservative uses of oil-emulsified probiotic encapsulations
US20040241150A1 (en) * 2002-12-19 2004-12-02 Hargis Billy M. Defined competitive exclusion cultures for food borne pathogens
AU2003300208A1 (en) 2003-01-06 2004-08-10 Nutrition Physiology Corporation Compositions and methods for reducing the pathogen content of meat and meat products
WO2004104175A2 (en) * 2003-05-14 2004-12-02 University Of Georgia Research Foundation, Inc. Probiotic bacteria and methods
EP2319863A1 (de) * 2003-06-23 2011-05-11 North Carolina State University Fructo-Oligosaccharidverbrauchsverbindungen codierende Lactobacillus-acidophilus-Nukleinsäuren und Verwendungen dafür
WO2005000034A2 (en) * 2003-06-23 2005-01-06 Agtech Products, Inc. Lactic bacteria and its use in direct-fed microbials
CA2540467C (en) * 2003-09-30 2013-11-12 Kibow Biotech, Inc. Compositions and methods for augmenting kidney function
US20050100559A1 (en) * 2003-11-07 2005-05-12 The Procter & Gamble Company Stabilized compositions comprising a probiotic
US8894991B2 (en) * 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
MY143693A (en) 2004-03-24 2011-06-30 Nestec Sa Shelf stable product wih living micro-organisms
US20080126195A1 (en) * 2004-07-22 2008-05-29 Ritter Andrew J Methods and Compositions for Treating Lactose Intolerance
CA2607949C (en) 2005-05-31 2012-09-25 Thomas William-Maxwell Boileau Feline probiotic bifidobacteria
AU2006253006B8 (en) 2005-05-31 2011-09-15 Alimentary Health Ltd Feline probiotic Lactobacilli
WO2007070052A2 (en) 2005-12-14 2007-06-21 Oxthera, Inc. Pharmaceutical compositions and methods for treating or preventing oxalate-related disease
DE602006020347D1 (de) 2005-12-16 2011-04-07 Oxthera Inc Zusammensetzungen und verfahren zur oxalatreduktion
US8968721B2 (en) 2005-12-28 2015-03-03 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
ES2470340T3 (es) 2005-12-28 2014-06-23 Advanced Bionutrition Corporation Vehículo de administración para bacterias probi�ticas que comprende una matriz seca de polisac�ridos, sac�ridos y polioles en forma vítrea
EP2117354B1 (de) * 2006-12-18 2018-08-08 Advanced BioNutrition Corp. Trockenes nahrungsmittel mit lebendem probiotikum
RU2436581C2 (ru) 2007-02-01 2011-12-20 Дзе Иамс Компани Способ уменьшения воспаления и снижения стресса у млекопитающего
BRPI0808145A2 (pt) * 2007-02-28 2021-03-23 Mead Johnson Nutrition Company Produto contendo probiótico inativado para crianças ou lactentes.
TW200904340A (en) * 2007-05-11 2009-02-01 Mannatech Inc Processing of natural polysaccharides by selected non-pathogenic microorganisms and methods of making and using the same
JP5259253B2 (ja) * 2008-05-19 2013-08-07 森下仁丹株式会社 シームレスカプセル
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
EP2293802A4 (de) * 2008-06-25 2011-11-09 Ritter Pharmaceuticals Inc Lactosezusammensetzungen mit reduziertem lactosegehalt
JP2009102324A (ja) * 2008-11-27 2009-05-14 Morishita Jintan Kk 乳酸菌含有血中アンモニア低減剤
FR2939045B1 (fr) * 2008-12-02 2010-12-31 Daniel Sincholle Compositions pharmaceutiques et nutritionnelles et methode utile pour prevenir et traiter l'inflammation colique et l'endotoxemie metabolique
EP2400839B1 (de) 2009-02-24 2016-09-07 Ritter Pharmaceuticals, Inc. Präbiotische formulierungen und verwendungsverfahren dafür
CA2756883C (en) 2009-03-27 2018-01-09 Advanced Bionutrition Corp. Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
CA2763074C (en) 2009-05-26 2021-02-23 Moti Harel Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
SG182317A1 (en) 2010-01-28 2012-08-30 Advanced Bionutrition Corp Dry glassy composition comprising a bioactive material
US7888062B1 (en) 2010-02-01 2011-02-15 Microbios, Inc. Process and composition for the manufacture of a microbial-based product
US8445226B2 (en) 2010-02-01 2013-05-21 Microbios, Inc. Process and composition for the manufacture of a microbial-based product
EP2563372A4 (de) 2010-04-28 2013-10-02 Ritter Pharmaceuticals Inc Präbiotische formulierungen und verwendungsverfahren dafür
IT1405395B1 (it) * 2010-08-05 2014-01-10 Proge Farm Srl Composizioni di probiotici e oli e loro uso.
DK2603100T3 (en) 2010-08-13 2018-08-06 Advanced Bionutrition Corp DRY STABILIZING COMPOSITION FOR STORAGE OF BIOLOGICAL MATERIALS
WO2012044984A1 (en) 2010-09-30 2012-04-05 The Board Of Trustees Of The University Of Arkansas Methods of selecting and using therapeutic and prophylactic probiotic cultures to reduce bacterial pathogen loads
CL2010001628A1 (es) 2010-12-30 2011-04-25 Univerisidad De Concepcion Alimento probiotico para peces que comprende lactobacillus plantarum, lactococcus lactis lactis, pediococcus acidilactic, pediococcus damnosus y/o plantarum, harina y descartes de pescado, poroto de soya, harina de trigo, aceite de pescado y almidon de maiz; y proceso de elaboracion de dicho alimento.
KR101166798B1 (ko) 2011-12-19 2012-07-26 김대현 락토바실러스 애시도필러스 엘비의 사균을 포함하는 알레르기 질환의 치료 또는 예방용 의약 조성물
BR112016031000B1 (pt) 2014-07-01 2022-01-25 Probi USA, Inc. Forma de dosagem em camadas e método para fazer a mesma
ES2966909T3 (es) * 2014-08-13 2024-04-25 Akeso Biomedical Inc Compuestos y composiciones antimicrobianos, y usos de los mismos
US20170333494A1 (en) * 2014-11-10 2017-11-23 Glaxosmithkline Intellectual Property Development Limited Probiotic therapeutic applications
EP3229595B1 (de) 2014-12-12 2021-02-03 The Regents of the University of California Reduktion von milchglykanen und deren abbauprodukten im darm von neugeborener
JP6889699B2 (ja) 2015-07-29 2021-06-18 アドバンスド バイオニュートリション コープ． 特定栄養用途のための安定乾燥プロバイオティクス組成物
US10653658B2 (en) 2015-08-11 2020-05-19 Akeso Biomedical, Inc. Biofilm inhibiting compositions enhancing weight gain in livestock
BR112018002045B1 (pt) 2015-08-11 2022-06-14 Akeso Biomedical, Inc Método não terapêutico para melhorar o crescimento de um animal, uso de um complexo de fe(iii) para fabricar um produto alimentício, e, produto alimentício contendo dito complexo
WO2017217350A1 (ja) 2016-06-13 2017-12-21 株式会社村田製作所 抗菌抗ウイルス薬、抗菌抗ウイルス部材、及び抗菌抗ウイルス薬の製造方法
US10258567B1 (en) 2016-11-17 2019-04-16 Grace Procurements Llc Vaginal probiotic products and related processes
RU2674772C1 (ru) * 2017-11-09 2018-12-13 Тарас Владимирович Герунов Способ профилактики отравлений у животных
CN110643533B (zh) * 2019-09-24 2020-11-13 扬州大学 降解油脂的干酪乳杆菌及其应用
US20230135760A1 (en) 2020-03-16 2023-05-04 Biosearch, S.A. Biocomposites comprising probiotics, collagen and bacterial extracellular polysaccharide and uses thereof
CN111560330B (zh) * 2020-05-12 2022-04-26 天津科技大学 一种具有免疫调节、抗炎和抗宫颈癌作用的干酪乳杆菌及应用
WO2022082027A1 (en) * 2020-10-15 2022-04-21 University Of Louisville Research Foundation, Inc. Probiotic delivery systems and methods of making and using
CN116887690A (zh) * 2020-12-25 2023-10-13 株式会社林原 家畜和/或家禽的生产性改善方法及肠内菌丛改善方法
CN112625979B (zh) * 2021-01-14 2023-01-06 四川大学华西医院 一种对抗幽门螺杆菌的干酪乳杆菌及其应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2421066A1 (de) 1974-05-02 1976-03-25 Solco Basel Ag Bifidobakterien enthaltendes praeparat
US3957974A (en) 1974-11-05 1976-05-18 Seikenkai Method for deodorization of excrements
JPS52102419A (en) 1976-02-23 1977-08-27 Seikenkai Lactic acid producing bacillus preparation
US4210672A (en) 1976-04-02 1980-07-01 Seikenkai Preparation of yogurt
JPS52154590A (en) 1976-05-21 1977-12-22 Seikenkai Cultivating and preserving method of deodorising lactobucillus and liling cell preparation
JPS587297B2 (ja) 1976-05-21 1983-02-09 秦 興世 脱臭剤とその製造方法及び保存法
JPS5911177A (ja) * 1982-07-12 1984-01-20 Seikenkai 新規乳酸桿菌
JPS60149527A (ja) 1984-01-17 1985-08-07 Seikenkai 生体内脱臭剤
US4839281A (en) 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
US5804179A (en) 1985-12-31 1998-09-08 Research Corporation Technologies, Inc. Lactobacillus compositions and methods for treating urinary tract infections
AU624067B2 (en) 1986-12-12 1992-06-04 Biorem C.C. Preparation suitable for use in the treatment of enteric disorders
SE469875C (sv) 1991-07-25 1997-04-14 Probi Ab Stam av tarmkoloniserande Lactobacillus samt komposition för profylax eller behandling av infektioner i magtarmkanalen
JP2506314B2 (ja) * 1993-10-27 1996-06-12 全国農業協同組合連合会 家禽・豚の敗血症の予防・治療剤及び飼料
JP3653277B2 (ja) 1994-05-26 2005-05-25 ブラッコ エッセ ピ ア ラクトバチルス菌株、該菌株の組成物および該菌株の使用法
AUPM823094A0 (en) 1994-09-16 1994-10-13 Goodman Fielder Limited Probiotic compositions
AU4484997A (en) 1996-09-18 1998-04-14 Thomas F. Brennan Compositions containing cobalamin and amino acids
SE511524C2 (sv) * 1997-06-02 1999-10-11 Essum Ab Lactobacillus casei rhamnosus-stam samt farmaceutisk beredning för bekämpning av patogena tarmbakterier
US5965128A (en) 1997-08-13 1999-10-12 University Of Georgia Research Foundation Inc. Control of enterohemorrhagic E. coli 0157:H7 in cattle by probiotic bacteria and specific strains of E. coli
AU3380899A (en) * 1998-04-01 1999-10-18 Ganeden Biotech, Inc. Methods for reducing cholesterol using (bacillus coagulans) spores, systems and compositions
WO2000035465A2 (en) * 1998-12-11 2000-06-22 Urex Biotech Inc. Oral administration of lactobacillus for the treatment and prevention of urogenital infection
JP2000197469A (ja) * 1999-01-08 2000-07-18 New Food Creation Gijutsu Kenkyu Kumiai 血清脂質改善効果を有する機能性飲食品
SE523771C2 (sv) * 1999-05-21 2004-05-18 Probi Ab Sportdryck innehållande mikronäringsämnen i kombination med levande laktobaciller
WO2002058712A2 (en) * 2000-12-18 2002-08-01 Probio Health Probiotic compounds derived from lactobacillus casei strain ke01

Also Published As

Publication number Publication date
JP2010195778A (ja) 2010-09-09
US20020192202A1 (en) 2002-12-19
JP5186077B2 (ja) 2013-04-17
DE60133581D1 (de) 2008-05-21
US6797266B2 (en) 2004-09-28
EP1345613B1 (de) 2008-04-09
WO2002058712A3 (en) 2003-06-05
KR20040018319A (ko) 2004-03-03
WO2002058712A2 (en) 2002-08-01
IL156490A0 (en) 2004-01-04
CA2442602A1 (en) 2002-08-01
DE60133581T2 (de) 2009-06-04
JP2004525106A (ja) 2004-08-19
AU2002246679B2 (en) 2006-11-16
EP1345613A2 (de) 2003-09-24
BR0116349A (pt) 2003-12-23
MXPA03005465A (es) 2004-10-14
NZ526443A (en) 2005-03-24

Similar Documents

Publication Publication Date Title
ATE391509T1 (de) Von lactobacillus casei ke01 stamm abgeleitete probiotische verbindungen
ID30071A (id) Pemberian oral lactobacillus untuk pengobatan dan pencegahan infeksi urogental
CY1107671T1 (el) Νεα συνθεση γαλακτοολιγοσακχαριτη και η παρασκευη της
HUP0301939A2 (hu) Új probiotikumok hobbiállat-eledel kompozíciókhoz
MXPA04000808A (es) Cepas probioticas de lactobacillus salivarius.
BR0211442A (pt) Cepas de bifidobacterium probióticas
ATE302265T1 (de) Einen lactobacillus-stamm enthaltende zusammensetzung und verwendungen davon
BRPI0417826A (pt) bifidobactéria pseudolongum probiótica canina
PT1490077E (pt) Composição fotoprotectora para a pele administrável por via oral
HK1079104A1 (en) Orally administrable composition to human for the photoprotection of the skin
WO2004069156A3 (en) Inactivated probiotic bacteria and methods of use thereof
WO2005060709A3 (en) Methods of use of probiotic bifidobacteria for companion animals
MY125202A (en) Vaccine
MX2007002508A (es) Cepas que producen ferulato esterasa y metodos para usarlas.
UA94056C2 (uk) Застосування специфічних молочнокислих бактерій для одержання імуномодулюючих композицій
WO2003075953A3 (en) Immunomodulatory polymeric antigens for treating inflammatory pathogies
FR21C1005I2 (fr) Antigenes de streptococcus pyogenes et fragments d'adn correspondants
WO2003039260A3 (en) PROBIOTIC COMPOSITIONS
MXPA04005002A (es) Bacterias lacticas y su uso en el tratamiento y la prevencion del cancer.
BRPI0407176A (pt) Cepas de bifidobacterium possuindo a capacidade de produzir glutamina
ATE421990T1 (de) Zusammensetzung zur förderung der vermehrung von lactobacillus casei subsp. casei
DE69927930D1 (de) Zusammensetzung geeignet als Nahrungsmittelzusatz und zur Anwendung bei Darmerkrankungen sowie bei veränderter Darmflora
DE60115919T2 (de) Neuartige lactobacillus paracasei stämme
NO20014788D0 (no) En sammensetning for senkning av konsentrasjonen av sykdomsfremkallende tarmpeptider
RU2001135344A (ru) Штамм бактерий Lactobacillus rhamnosus 12L для приготовления биологически активных добавок, регулирующих микрофлору кишечника у детей раннего возраста

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties